Business Insider
My Markets Watchlist
Markets Stocks

American Bio Medica Corp. Stock , ABMC

0.00 0.00 0.00%
05:20:00 PM EDT 6/16/2025 NASO
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar


American Bio Medica Stock Snapshot

4,809.85
Market Cap in USD
48.10 M
Number of Shares
48.10 M
Total Number of Shares
0.00
Dividend in USD
0.00
Dividend Yield
-0.03
EPS in USD
-0.05
Book Value per Share in USD
-0.02
Cash Flow per Share in USD

American Bio Medica Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price

Income Statements in Mio. USD

2022 2021 2020 2019 2018 2017 2016
Sales 0.91 2.22 4.15 3.66 3.87 4.91 5.61
Change of sales in % -58.84 -46.52 13.46 -5.60 -21.20 -12.39 -11.21
Gross profit on sales -0.10 0.55 1.24 1.18 1.29 2.00 2.49
Gross profit on sales change in % - -55.74 4.56 -8.07 -35.50 -19.80 -12.78
Operating income -1.24 -1.18 -0.62 -0.59 -0.76 -0.31 -0.26
Operating income change in % -5.34 -89.86 -4.72 22.18 -145.02 -21.01 -13.72
Income before tax -1.41 -0.46 -0.79 -0.69 -1.03 -0.55 -0.34
Income before tax change in % -205.42 41.94 -15.74 33.14 -88.26 -59.82 -3.02
Income after tax -1.41 -0.46 -0.80 -0.68 -1.03 -0.55 -0.35
Income after tax change in % -204.54 41.83 -16.89 33.75 -88.62 -57.97 -3.60

Balance Sheet in Mio. USD

2022 2021 2020 2019 2018 2017 2016
Total liabilities 3.61 2.83 3.18 2.87 2.62 2.27 2.35
Long-term liabilities per share 0.00 0.00 0.03 0.04 0.02 0.03 0.03
Equity -2.34 -0.94 -1.26 -0.79 -0.15 0.62 1.03
Equity change in % -147.78 24.84 -58.99 -441.10 -123.43 -39.22 6.66
Balance sheet total 1.27 1.88 1.93 2.08 2.48 2.89 3.37
Balance sheet total change in % -32.61 -2.23 -7.31 -16.04 -14.39 -14.24 -11.22

Key Data in USD

2022 2021 2020 2019 2018 2017 2016
Sales per share 0.02 0.05 0.12 0.11 0.13 0.17 0.20
P/E ratio (year end quote, basic EPS) - - - - - - -
P/E ratio (year end quote, diluted EPS) - - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Equity ratio in % -184.32 -50.13 -65.21 -38.02 -5.90 21.55 30.41
Debt ratio in % 284.32 150.13 165.21 138.02 105.90 78.45 69.59

American Bio Medica Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
MORONEY JOHN J 07/14/2021 495,500.00 1,986,108.00 0.06 Sell No
Jerome Peter 06/30/2020 35,461.00 80,610.00 0.37 Buy No
Neff Jean 06/30/2020 35,461.00 66,226.00 0.37 Buy No
Davis Chaim 06/30/2020 35,461.00 240,561.00 0.37 Buy No

American Bio Medica Dividend Calendar

Date Name Dividend *yield Currency
2022 American Bio Medica Corp. 0.00 0.00 USD
2021 American Bio Medica Corp. 0.00 0.00 USD
2020 American Bio Medica Corp. 0.00 0.00 USD
2019 American Bio Medica Corp. 0.00 0.00 USD
2018 American Bio Medica Corp. 0.00 0.00 USD
2017 American Bio Medica Corp. 0.00 0.00 USD
2016 American Bio Medica Corp. 0.00 0.00 USD
2015 American Bio Medica Corp. 0.00 0.00 USD
2014 American Bio Medica Corp. 0.00 0.00 USD
2013 American Bio Medica Corp. 0.00 0.00 USD
2012 American Bio Medica Corp. 0.00 0.00 USD
2011 American Bio Medica Corp. 0.00 0.00 USD
2010 American Bio Medica Corp. 0.00 0.00 USD
2009 American Bio Medica Corp. 0.00 0.00 USD
*Yield of the Respective Date

American Bio Medica Calendar

Event Estimate Info Date

American Bio Medica Past Events

Event Actual EPS Info Date

American Bio Medica Profile

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The firm's products include Rapid Drug Screen, Rapid ONE, RDS InCup, Rapid TOX, Rapid TOX Cup II, and OralStat. Its products are related to urinalysis, oral fluids, alcohol testing, hair testing, pregnancy testing, and lab partners. The company was founded by Stan Cipkowski and Edmund M. Jaskiewicz on April 2, 1986 and is headquartered in Kinderhook, NY.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
10
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.
OSZAR »